Medicare Enrolled

Dr. Minesh Nandi, MD

Hematology & Oncology · Hiram, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
144 BILL CARRUTH PKWY STE 3100, Hiram, GA 30141
6783631940
Registered in NPPES since 2017
NPI: 1306376421 verify on NPPES ↗
High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nandi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nandi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nandi

Dr. Minesh Nandi is a hematology & oncology specialist in Hiram, GA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Nandi performed 66 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Nandi received a total of $2,458 from 42 pharmaceutical and/or device companies across 113 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nandi is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years of NPI registration ▲ 66 Medicare services $2,458 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
66
Medicare services
Bottom 6% in GA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
36 $66 $156
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $46 $244
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,458
Total received (2023-2024)
Avg $1,229/year across 2 years
Bottom 43% in GA for hematology & oncology
42
Companies
113
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,078
2023
$379

Payments by company (2024)

PFIZER INC.
$241
Incyte Corporation
$158
SOBI, INC
$148
Rigel Pharmaceuticals, Inc.
$140
Merck Sharp & Dohme LLC
$135
AstraZeneca Pharmaceuticals LP
$109
SEAGEN INC.
$100
E.R. Squibb & Sons, L.L.C.
$84
Novartis Pharmaceuticals Corporation
$82
Lilly USA, LLC
$72
Eisai Inc.
$72
ARRAY BIOPHARMA INC
$58
Daiichi Sankyo Inc.
$50
Celgene Corporation
$49
Exelixis Inc.
$47
Astellas Pharma US Inc
$44
Novocure Inc.
$41
Gilead Sciences, Inc.
$36
GlaxoSmithKline, LLC.
$33
Janssen Biotech, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$28
PUMA BIOTECHNOLOGY, INC.
$25
TAIHO ONCOLOGY, INC.
$21
GENZYME CORPORATION
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SERVIER PHARMACEUTICALS LLC
$21
BeiGene USA, Inc.
$19
Adaptive Biotechnologies Corporation
$18
Mirati Therapeutics, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
Genmab U.S., Inc.
$17
MorphoSys, US Inc.
$17
ABBVIE INC.
$17
Karyopharm Therapeutics Inc.
$16
Organon Llc
$15
Sumitomo Pharma America, Inc.
$14
Blueprint Medicines Corporation
$14
Genentech USA, Inc.
$14
Legend Biotech USA Inc.
$14
Top 3 companies account for 26.4% of 2024 payments
All-time payments by company (2023-2024) ›
PFIZER INC.
$241
Rigel Pharmaceuticals, Inc.
$238
Incyte Corporation
$158
Merck Sharp & Dohme LLC
$151
SOBI, INC
$148
Novartis Pharmaceuticals Corporation
$116
E.R. Squibb & Sons, L.L.C.
$116
AstraZeneca Pharmaceuticals LP
$109
SEAGEN INC.
$100
Eisai Inc.
$89
Astellas Pharma US Inc
$77
Lilly USA, LLC
$72
Celgene Corporation
$63
ARRAY BIOPHARMA INC
$58
Gilead Sciences, Inc.
$53
Daiichi Sankyo Inc.
$50
GlaxoSmithKline, LLC.
$49
Exelixis Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$46
Novocure Inc.
$41
Genentech USA, Inc.
$31
ABBVIE INC.
$31
Janssen Biotech, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$28
PUMA BIOTECHNOLOGY, INC.
$25
TAIHO ONCOLOGY, INC.
$21
GENZYME CORPORATION
$21
SERVIER PHARMACEUTICALS LLC
$21
BeiGene USA, Inc.
$19
TerSera Therapeutics LLC
$19
Adaptive Biotechnologies Corporation
$18
Mirati Therapeutics, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
Genmab U.S., Inc.
$17
MorphoSys, US Inc.
$17
Karyopharm Therapeutics Inc.
$16
Organon Llc
$15
Seagen Inc.
$15
Sumitomo Pharma America, Inc.
$14
Blueprint Medicines Corporation
$14
Legend Biotech USA Inc.
$14
Spectrum Pharmaceuticals Inc.
$13
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · AYVAKIT · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · Columvi · DARZALEX · DOPTELET · ENHERTU · ERLEADA · Enhertu · Epkinly · IBRANCE · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Optune · PADCEV · PROMACTA · Padcev · Pomalyst · REBLOZYL · ROLVEDON · Rezlidhia · SARCLISA · TAGRISSO · TIVDAK · TUKYSA · Tibsovo · VENCLEXTA · VERZENIO · Vitrakvi · XARELTO · XPOVIO · XTANDI · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Hiram?
Compare hematology & oncology specialists in the Hiram area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
100
County median income
$94,557
Nearest hospital to ZIP centroid (approximate)
WELLSTAR PAULDING MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nandi is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nandi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Nandi performed 36 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nandi receive payments from pharmaceutical companies?
Yes. Dr. Nandi received a total of $2,458 from 42 companies across 113 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nandi's costs compare to other hematology & oncology specialists in Hiram?
Dr. Nandi's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Nandi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →